0001181431-11-042921.txt : 20110728 0001181431-11-042921.hdr.sgml : 20110728 20110728204720 ACCESSION NUMBER: 0001181431-11-042921 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110718 FILED AS OF DATE: 20110728 DATE AS OF CHANGE: 20110728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linden Robert V CENTRAL INDEX KEY: 0001433664 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 11995127 MAIL ADDRESS: STREET 1: 236 WOODEN BRIDGE ROAD CITY: HOLLAND STATE: PA ZIP: 18966 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rrd318627.xml LINDEN FORM 4 11-07-28 X0303 4 2011-07-18 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001433664 Linden Robert V C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 0 1 0 0 Senior VP Sales, The Americas Common Stock 2011-07-18 4 F 0 30 7.44 D 32211 D Common Stock 2011-07-27 4 F 0 209 7.06 D 32002 D Stock Option (Right to Buy) 7.10 2011-07-26 4 A 0 13733 0 A 2011-07-26 2018-07-26 Common Stock 13733 13733 D These shares represent shares withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 18, 2007. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 27, 2009. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years. /s/ Aaron M. Grossman Attorney-in-Fact 2011-07-28